3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
2
Not yet recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
2
Breast
2
Genitourinary
1
Conditions
Breast Neoplasms
7
Motor Activity
4
Neoplasms
3
Colorectal Neoplasms
3
Smoking Cessation
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Behavior
2
Smoking
1
Skin Cancer Prevention
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Lymphedema
1
Colorectal Cancer Screening
1
Colonic Neoplasms
1
Body Weight Changes
1
Body Weight
1
Anxiety Disorders
1
Interventions
Paclitaxel
37
Carboplatin
28
pembrolizumab
19
Surveys and Questionnaires
11
temsirolimus
10
Radiotherapy
10
Cisplatin
10
Doxorubicin
9
Bevacizumab
9
lenvatinib
8
Docetaxel
8
Nivolumab
7
Metformin
7
Gemcitabine
7
Early Intervention, Educational
7
Counseling
7
Sirolimus
6
Radiation
6
Megestrol Acetate
6
Indocyanine Green
6
olaparib
5
Topotecan
5
Therapeutics
5
Psychiatric Rehabilitation
5
Methods
5
Letrozole
5
Ipilimumab
5
Chemotherapy, Adjuvant
5
ridaforolimus
4
Trastuzumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Endometrial Neoplasms
×
Motivational Interviewing
×
Clear all
NCT05162846
2026-03-09
MiGHT
University of Michigan Rogel Cancer Center
Phase NA
Completed
831 enrolled
NCT03210129
2019-03-14
MIPAClux
Luxembourg Institute of Health
Phase NA
Completed
25 enrolled